Developing pharma projects

Arandi develops new medical solutions from ideas and rough plans through exploratory investigations to proof-of-concept  trials. We do IND submissions and arrange regulatory meetings. We help sponsor companies to do it, and we do it for ourselves, too.

The Arandi people are life science professionals and can provide comprehensive medical, scientific, regulatory, and logistics support for clinical products development throughout Scandinavia. We have tailored our services to many large and small sponsors: inventors, investors, small and medium-sized biotech companies, as well as Big Pharma.  Our track record includes pharma and biotech products, herbal medicines, and med tech devices.

Clinical trials for regulatory purposes

We insist that cost-effective clinical trials require detailed knowledge of the regulatory agency processes and a realistic appreciation of how study logistics may be affected by local market events. Success also depends on getting access to local opinion leaders and on being able to support their staff throughout the trial.

Our operational competence comes from having worked with all aspects of clinical trials throughout Scandinavia for many years. Experience and our network helps us to plan yet be quick and fexible when that is needed.  If a sponsor so wishes, we can build ad hoc advisory groups of regional specialists.

Thinking global, acting local

Arandi is based in Stockholm – ‘the capital of Scandinavia’- and is ideally located to co-ordinate trials in Sweden, Denmark, Norway, and Finland. We have the necessary language skills, professional networks, and detailed understanding of regulatory processes.

The Nordic countries have separate routines for trial applications and site monitoring. Our people have the necessary experience to deal with these different sets of regulations without loss of precious time.

Investment ventures

Arandi invests in development projects where our experience can make a significant difference. We are particularly keen to explore how generics can be incorporated into new formulations so that drug therapy is made more effective and/or safer through technology- enabled individual dosing..

The motto for Arandi’s venture projects is “Empower the Patient”. We see great commercial opportunities for IP protected products that  enable the patient to have a more active role in treating his own condition. The motto "Empower the Patient" is chosen to show our commitment to develop intelligent medical solutions for the individual.